Compugen Market Cap

Compugen has a market cap or net worth of $258.13 million as of April 28, 2026. Its market cap has increased by 128.84% in one year.

Market Cap

258.13M

Enterprise Value

111.67M

1-Year Change

128.84%

Ranking

#3674

Market Cap Chart

Since December 31, 2002, Compugen's market cap has increased from $46.50M to $258.13M, an increase of 455.12%. That is a compound annual growth rate of 7.62%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	258.10M	80.36%
Dec 31, 2025	143.10M	4.45%
Dec 31, 2024	137.00M	-21.58%
Dec 29, 2023	174.70M	181.77%
Dec 30, 2022	62.00M	-82.82%
Dec 31, 2021	360.80M	-64.38%
Dec 31, 2020	1.01B	183.96%
Dec 31, 2019	356.70M	220.49%
Dec 31, 2018	111.30M	-12.91%
Dec 29, 2017	127.80M	-50.45%
Dec 30, 2016	257.90M	-19.68%
Dec 31, 2015	321.10M	-5.97%
Dec 31, 2014	341.50M	4.27%
Dec 31, 2013	327.50M	91.74%
Dec 31, 2012	170.80M	1.73%
Dec 30, 2011	167.90M	3.83%
Dec 31, 2010	161.70M	16.92%
Dec 31, 2009	138.30M	1,033.61%
Dec 31, 2008	12.20M	-72.95%
Dec 31, 2007	45.10M	-37.45%
Dec 29, 2006	72.10M	-38.95%
Dec 30, 2005	118.10M	-14.61%
Dec 31, 2004	138.30M	4.38%
Dec 31, 2003	132.50M	184.95%
Dec 31, 2002	46.50M	-

View and export this data all the way back to 2002. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Anavex Life Sciences	309.52M
Abeona Therapeutics	306.60M
LENZ Therapeutics	294.10M
Minerva Neurosciences	288.26M
Editas Medicine	284.81M
NovaBridge Biosciences	283.34M
Zentalis Pharmaceuticals	282.31M
AC Immune	281.73M

Market Cap Rankings